Trials / Unknown
UnknownNCT06120413
18F-LN1 PET/CT in Urothelial Carcinomas
Clinical Evaluation of 18F-LN1 PET/CT for Imaging of Nectin-4 in Urothelial Carcinomas
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 30 (estimated)
- Sponsor
- Sichuan Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The clinical feasibility of 18F-LN1 PET/CT will be evaluated in 30 patients with urothelial carcinoma, and the results will be compared with those of 18F-FDG.
Detailed description
This study aims to evaluate the recognition efficiency of 18F-LN1 and 18F-FDG PET imaging for tumor target Nectin-4 in patients with urothelial carcinoma. The main method is to compare the results of visually interpreted PET images with histopathological results (through surgery or biopsy), which are the gold standard for final diagnosis.
Conditions
Timeline
- Start date
- 2023-11-01
- Primary completion
- 2024-09-01
- Completion
- 2024-10-01
- First posted
- 2023-11-07
- Last updated
- 2023-11-07
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06120413. Inclusion in this directory is not an endorsement.